~//bj.watch/overview
live

Latest signal

last curated pass Nov 9, 2026 · 8 public entries · source-aware summaries from 6 legacy curated cards plus llm-wiki tweets

# all # health # longevity # nutrition # sleep # concepts

Recent curated signals

Commercial “Scan of your heart to make sure all is well”: the feed’s first disclosed Prenuvo paid partnership turns five cardiac-MRI percentiles into a Blueprint-marketplace product plug — the heart-disease framing verifies against the American Heart Association, but the scan’s own materials say it cannot diagnose heart disease or see artery blockages, and the “20 yr old” percentiles are another unpublished private report Johnson posted the feed’s first explicitly disclosed Prenuvo partnership: “Scan of your heart to make sure all is well. / Heart disease is the #1 cause of death, also the most preventable chronic disease. / I partnered with Prenuvo to make this easy for you. / Below are my results to encourage you to find out yours.” (339 likes, 8 reposts, 40 replies; November 9, 00:45 UTC, with an attached results photo), following up one minute later that “This scan is in the Blueprint marketplace” (23 likes, 1 repost, 4 replies; 00:46 UTC — a self-reply in the same thread, pointing to the same Blueprint-marketplace link attached to his October 29 sauna-marketplace reply). The framing statistics verify in direction: heart disease is the leading cause of death in the U.S. and globally, and the American Heart Association says as much as 80% of heart disease and stroke is preventable — via risk-factor management (Life’s Essential 8: blood pressure, lipids, glucose, weight, tobacco, activity, diet, sleep), restated in the AHA’s March 31, 2026 dietary-guidance statement (10.1161/CIR.0000000000001435). The product is real: Prenuvo’s Advanced Heart Health Scan, launched with Myocardial Solutions on August 27, 2026, uses FDA-cleared MyoStrain® analysis to quantify myocardial strain across 48 ventricular segments (37 left, 11 right), summarized as a MyoHealth® score — the share of segments with normal contraction — plus estimated ejection fraction; his radiologist quote names the same instrument (“Bryan’s Myohealth assessment indicates age equivalent myocardial function to a healthy person in their early 20s”). Boundaries: Prenuvo’s own product page states the report “does not diagnose heart disease, assess for coronary artery disease, or replace standard cardiac testing” and that MyoStrain cannot see blockages, plaque, or coronary artery disease — so “make sure all is well” overstates what the scan can establish; the five percentiles (“top 5% of 20 yr olds” myocardial function, more blood pumped than “95% of 20 yr old men,” higher ejection fraction and stronger contraction than “80% of healthy 20 yr olds,” “better synched than 92% of healthy 20 yr olds”) summarize an unpublished private report against an undisclosed normative cohort — the same pattern as the October 27 whole-body-MRI readout, where no professional society recommends screening MRI of asymptomatic people; the AHA’s preventability case rests on risk-factor management, not imaging, and “most preventable chronic disease” is gloss beyond the AHA’s wording; “One minor concern was identified and was most likely a measurement artefact” is an undisclosed finding with an unpublished interpretation; the post is advertising for a partner product sold through his own marketplace, an incentive structure the post does not mention; engagement figures drift and were read at curation time (November 9, ~03:35 UTC). The dashboard records an attributed commercial partnership with verified product and epidemiologic context — not evidence that heart scanning improves outcomes, a validated age-equivalence metric, or medical advice. Opinion “Deep focus replacing choppy social media has increased my life fulfillment by 10x”: an unfalsifiable self-report whose observable half verifies — the audit window’s two longest posting gaps sit exactly where the claimed break sits — wrapped around an announcement tease Johnson posted an attention-and-fulfillment self-report: “I’ve been in deep focus for the past few days cooking up some really fun stuff that I’m excited to share. My time on social media has been minimal. The deep focus replacing choppy social media has increased my life fulfillment by 10x. I really hope that we transition soon to a world where we can still play human social games without it needing screens or fragmenting the mind.” (315 likes, 6 reposts, 32 replies; November 9, 01:39 UTC — the newest item on the timeline at curation time, November 9, ~03:35 UTC). The claim’s core number is an unfalsifiable self-report — “life fulfillment” has no metric, baseline, or measurement, and “10x” is rhetorical magnitude, not data. But the observable half verifies in the audit record: the 40-post window shows its two longest posting gaps exactly where the claimed break sits — 1 day 20 hours 14 minutes from the November 5, 21:13 UTC market meme to the November 7, 17:28 UTC aphorism, then a second 31-hour gap from that aphorism to the November 9, 00:45 UTC heart-scan partnership post — a cadence drop consistent with “minimal” social-media time, though the partnership advertisement itself arrived inside the claimed quiet window, so the break is reduced cadence, not absence. “Cooking up some really fun stuff” is an announcement tease with no content disclosed — the same pattern as prior preview posts that later resolved into product launches. The screens-and-fragmentation framing extends the feed’s long-running attention ideology (the October “motivation problem is a sleep problem” post, the year’s screen-time remarks) without new evidence. The dashboard records an attributed behavior self-report with a verified cadence change — not evidence that quitting social media increases fulfillment, a wellness directive, or medical advice. Media “always improving my protocol”: the feed’s biggest recorded post (26,887 likes) turns the November 5 AI-stock sell-off into a red-light-therapy joke — a red-lit profile shot facing a wall of red tickers that Business Insider picked up the next day as the sell-off’s signature longevity meme Johnson posted the audited window’s highest-engagement message — and the largest like count the dashboard has recorded on any audited post: “always improving my protocol” (26,887 likes, 748 reposts, 380 replies; November 5, 21:13 UTC, with an attached photo). The photo, as described in next-day coverage, is a red-lit profile shot facing a monitor wall of red stock tiles — turning that day’s AI-led market sell-off into a red-light-therapy joke. The market context verifies: on November 5 the Nasdaq fell 5.5% into correction territory, the S&P 500 dropped 4.4%, and the Dow shed more than 1,800 points, with Nvidia down 9.3% and AMD down 17.3% (Business Insider, November 6, 2026). The pickup verifies: Business Insider’s November 6 sell-off meme roundup quotes this exact post — “Even longevity bro Bryan Johnson got in on the act, reimagining the sea of red in the market as a dose of red-light therapy” — and Thunder Dungeon’s same-day roundup describes “a red-lit profile shot facing a monitor full of red stock tiles.” The joke lands because red-light exposure is a real tracked item in his own stack: the July 22 routine snapshot lists morning “light and red-light exposure,” the August eye protocol includes 630nm low-level red light, and the October energy post budgets 2 kWh/day for red-light therapy. Boundaries: the post is self-mockery, not a health claim — a screen’s red glow delivers no therapeutic dose (no wavelength specification, irradiance, or exposure protocol, and no outcome is claimed); the media pickup is reception evidence about the account’s cultural reach, not evidence about any intervention; engagement figures drift and were read at curation time (November 7, ~03:15 UTC). The dashboard records an attributed media-reception moment with verified market and coverage context — not evidence that a screen’s red glow is red-light therapy, a health claim, or medical advice. Sleep “The first thing I do when arriving at a hotel is make my room as cold as it can get”: the travel version of the tracked cold-bedroom directive — direction aligned with sleep-thermoregulation consensus (60–67°F), but “as cold as it can get” is an unmeasured overshoot of every published band Johnson posted a travel-habit one-liner extending the tracked thermal-sleep storyline: “The first thing I do when arriving at a hotel is make my room as cold as it can get.” (2,634 likes, 44 reposts, 195 replies; November 5, 14:24 UTC). This is the travel version of the feed’s October 27 “Your bedroom should be cold, dark and boring” directive (10,810 likes — that window’s highest engagement) and the October 20 energy post’s line item for evening AC “holding sleep temperature at 67°F.” The direction is consensus sleep-thermoregulation guidance: core body temperature naturally decreases to initiate sleep, and a cool bedroom facilitates that drop — the National Sleep Foundation’s bedroom-environment guidance identifies roughly 60–67°F as optimal for high-quality sleep in most adults, a band his own 67°F home setting sits at the top of. Boundaries: “as cold as it can get” is an unmeasured overshoot of every published band — hotel HVAC minimums vary widely, no temperature was measured or reported, and pushing a room below the guidance range is not an evidence-backed upgrade (the same guidance stresses individual variation and experimentation); the post is an N=1 travel habit with no sleep data attached; environmental sleep hygiene supports but does not treat established insomnia — the AASM suggests against sleep hygiene as a stand-alone therapy for chronic insomnia disorder (Edinger et al., J Clin Sleep Med 2021, 10.5664/jcsm.8988); the post names no study. The dashboard records an attributed sleep-environment habit with verified consensus direction — not a measured result, a reader thermostat setting, or medical advice. Research claim “Closer to a cliff”: the menopause post’s “300M lab results” is real — 300 million tests across NHANES and Clalit in Nature Medicine, finding step-like jumps in 52/90 tests at the final menstrual period — but the study is three weeks old, retrospective, and its “cliff” framing is already publicly contested by menopause clinicians Johnson relayed a women’s-health claim: “Menopause was thought to be a gradual decline. This new study of 300M lab results suggests it may be closer to a cliff.” (426 likes, 14 reposts, 35 replies; November 4, 17:04 UTC, with an attached figure). The study verifies: Pridham, Hayut, Lavi-Shoseyov, Neeman, Hovav, Toledano, Alon, “Population-scale reconstruction of menopause dynamics reveals a physiological cliff at the final menstrual period,” Nature Medicine, October 12, 2026 (10.1038/s41591-026-04614-0, open access) — the Weizmann/Clalit team applied an astronomy-inspired temporal deconvolution to two cohorts (NHANES 1999–2022 and Israel’s Clalit health insurer, 1.3 million female individuals aged 30–70) totaling 300 million laboratory tests, reconstructing final-menstrual-period-anchored trajectories from cross-sectional data. They found step-like jumps at the FMP in 52 of 90 US laboratory tests (jump sizes 0.1–1.4 s.d.) across endocrine, skeletal, hepatic, renal, inflammatory, and lipid systems; the jumps are absent in males, concordant across the two populations (r = 0.89), preceded by accelerated sex-hormone change ~12–15 years before the FMP (AMH ~15 years, FSH ~14, estradiol ~12 — about 7 years earlier than prior longitudinal work), and attenuated in self-reported menopausal-hormone-therapy users, especially bone, liver, and kidney measures. Boundaries: “300M lab results” is 300 million tests, not patients — the paper’s own abstract says “300 million laboratory tests”; the study is three weeks old and built on retrospective cross-sectional data with self-reported menopause status, its own named limitations; the MHT attenuation is associational, with healthy-user and access bias the authors say needs prospective randomized testing; and Australian menopause clinicians publicly pushed back within a day — Martha Hickey called the “cliff-like” framing “unnecessarily alarming” and noted “physiological cliff is not a scientific or medical term,” with the long-running SWAN cohort indicating a roughly three-year gradual transition; the post names no study. The dashboard records an attributed research relay with an exactly verified corpus — not a reader hormone-therapy decision, evidence about any individual’s menopause timing, or medical advice. Research claim “Zombie cells may have a kill switch”: the post describes a real one-day-old Cell paper — senescent cells run low on DGLA, and repleting it kills them by ferroptosis while healthy cells survive — a mouse-and-dish result with one associational human genetics leg, and Johnson’s own “would be interesting if replicated in humans” is the accurate boundary Johnson relayed a senescence claim: “Zombie cells may have a kill switch / As we age, some cells stop dividing but refuse to die. / They’re called “zombie” (senescent) cells. They pile up and inflame the tissue around them which is bad for you body. / This research group figured out how to kill them in mice. / They found that these zombie cells run low on one fatty acid: DGLA. So they added it back causing many of the zombie cells to die while the healthy cells survived. / They died by ferroptosis where the cell’s outer membrane oxidizes and breaks. / Would be interesting if replicated in humans.” (589 likes, 31 reposts, 47 replies; November 4, 17:46 UTC). The paper verifies: Kuehnemann, Jezak, Mogck, … Wiley, “Fatty acid desaturation controls cellular fate decisions between senescence and ferroptosis,” Cell (10.1016/j.cell.2026.09.036; Buck Institute-led with University of Eastern Finland and collaborators), announced November 3, 2026 — one day before the post. The mechanism is as posted: senescent cells show altered PUFA metabolism with selectively reduced dihomo-gamma-linolenic acid (DGLA, 20:3 ω-6); repleting DGLA (200 µM) — or inhibiting delta-5-desaturase (D5D/FADS1), the enzyme that metabolizes it — induces ferroptosis selectively in senescent cells across multiple induced-senescence models while healthy cells largely survive; oral DGLA ethyl ester (400 mg/kg, 5 consecutive days) lowered senescent-cell burden (p16 luminescence, SA-β-gal, SASP factors) and improved adipose, liver, and kidney markers in aged 22–24-month mice; and in the human Kuopio Obesity Surgery Study, a FADS1 variant that promotes DGLA accumulation was associated with lower adipose-tissue senescence markers. Boundaries: the intervention evidence is cell culture and aged mice — the liver clearance and functional gains are male-only in the paper and DGLA increased steatotic area, possibly to store the excess administered lipid; 400 mg/kg oral gavage in mice is a research dose with no established human equivalent; the human leg is a genetic association in bariatric-surgery patients, not an intervention trial; “kill switch” is Johnson’s gloss and the post names no study — but its own closing hedge (“would be interesting if replicated in humans”) is exactly right. The dashboard records an attributed research relay with a verified one-day-old paper — not evidence readers should supplement DGLA, a senolytic therapy, or medical advice. Measurement “Apparently my mitochondria are stressed by this”: the deadlift arithmetic checks (245→425 lb is +74%), but post-workout GDF15 rises are a normal exercise-stress response in healthy humans — the unpublished N=1 series rides a marker that moves with any vigorous workout Johnson posted a training-plus-biomarker disclosure: “I’ve been training really hard to dunk a basketball. / Deadlift up 74% (245 → 425 lb) / Apparently my mitochondria are stressed by this. / We’ve been measuring GDF15 after workouts and it rises and falls according to the difficulty level of the workout.” (516 likes, 8 reposts, 79 replies; November 4, 19:21 UTC, with an attached photo). The arithmetic checks — 245→425 lb is +73.5%, rounding to the posted 74% — and the number continues the tracked dunk-training storyline (October 25: 385 lb × 5 from the floor at an estimated ~445 lb 1RM, 2.47× bodyweight). The biomarker context verifies: Kleinert, Hempel, … Plomgaard, “Exercise increases circulating GDF15 in humans,” Molecular Metabolism 2018;9:187-191 (10.1016/j.molmet.2017.12.016 — seven healthy males, 60 min cycling at 67% VO2max, plasma GDF15 +34% at exercise end and +64% at 120-min recovery, rising in every subject with skeletal muscle not the source), and the response is intensity- and duration-dependent in trained adults (ACSM Medicine & Science in Sports & Exercise 2019, 10.1249/01.mss.0000561999.22383.5c). Boundaries: his own series is unpublished N=1 — no assay, values, timepoints, or dataset are published; because acute vigorous exercise raises GDF15 in healthy humans by itself, a post-workout rise is an expected physiological stress response, not evidence of mitochondrial damage, and “apparently my mitochondria are stressed by this” is his interpretation of a normal exercise-stress marker (one already tracked in the psilocybin-Parkinson’s relay, where GDF15 is framed as a mitochondrial-stress signal); GDF15 also moves with illness, inflammation, pregnancy, and weight change, so workout-difficulty correlation is not a validated training metric. The dashboard records an attributed N=1 measurement disclosure with verified context literature — not evidence that hard training harms mitochondria, a reader biomarker to track, or medical advice. Research claim “Walking to motivating music increased exercise by 15%”: the number is a real lab finding — treadmill time-to-exhaustion, up 15% under motivational synchronous music in the 2009 Brunel study — but the post drops the condition that made it work: stride-matched tempo Johnson relayed a music-exercise claim: “Walking to motivating music increased exercise by 15%” (1,593 likes, 62 reposts, 81 replies; November 4, 03:27 UTC, with an attached figure), quote-posting his own November 1 “listening to music while exercising is one of life’s greatest joys” post. The figure verifies: Karageorghis, Mouzourides, Priest, Sasso, Morrish, Walley, “Psychophysical and Ergogenic Effects of Synchronous Music during Treadmill Walking,” Journal of Sport and Exercise Psychology 2009;31(1):18-36 (10.1123/jsep.31.1.18; PubMed 19325186) — 30 university-age participants walked to exhaustion starting at 75% heart-rate reserve under motivational synchronous music, neutral (“oudeterous”) synchronous music, and no-music control; “the motivational music elicited a 15% increase in treadmill endurance over control and a 6% increase over oudeterous music,” with the music manipulation accounting for 38% of endurance-time variance. Boundaries: the 15% is laboratory time-to-exhaustion on a treadmill — endurance in a single session, not “exercise” as free-living physical-activity volume; the effect belongs to synchronous music, where stride rate is deliberately kept in time with musical tempo, a condition “walking to motivating music” quietly drops; N=30 young Brunel students walking near exhaustion, one 2009 study; motivational quality of the tracks was participant-selected; the post names no study. The dashboard records an attributed research relay with an exactly verified percentage — not evidence that background music raises daily activity, a reader walking protocol, or medical advice.

// Reference paths

Move from feed to dossiers

Each route keeps source trails and medical caution visible.
Protocol Health

Habits, Longterm, and Don’ts for measurement loops, sleep consistency, oral care, exercise, and experimental-intervention caution.

 Protocol Longevity

Habits, Longterm, and Don’ts for biomarkers, healthspan basics, critiques, and low-confidence immortality claims.

 Protocol Nutrition

Habits, Longterm, and Don’ts for plant-led meals, Blueprint products, microplastics claims, and metabolic-drug caveats.

 Protocol Sleep

Habits, Longterm, and Don’ts for bedtime discipline, front-loading examples, and metric caution from tweet-backed sources.

 Reference Concepts

39 source-aware glossary entries, including concepts without dedicated wiki pages yet.

 entity Blueprint

Blueprint is bryan-johnson's longevity protocol, product company, and public measurement system. It began as Project Blueprint, an N=1 effort to measure Johnson's organs and biological aging, and later became a consumer

 concept Blueprint Protocol

The Blueprint Protocol is bryan-johnson's closed-loop health system: measure body state, consult scientific evidence, implement interventions, measure again, and update. Johnson treats the body as a system whose organs a

 concept Don't Die

Don't Die is bryan-johnson's community slogan, longevity philosophy, and civilizational frame. The official Don't Die page describes a community “united in defeating all causes of human and planetary death and building a

 concept Biomarker-driven longevity protocols

A biomarker-driven longevity protocol is a health system that treats the body as a measurable control system: collect biomarkers, choose interventions, re-measure, and iterate. project-blueprint is the most visible curre

 Signal Metrics

Inspect source velocity by range, content type, and fallback API state.